Gyon Technologies Capital Management, LP Ionis Pharmaceuticals Inc Transaction History

Gyon Technologies Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$34.54 - $47.25 $772,867 - $1.06 Million	-22,376 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$42.51 - $63.78 $372,387 - $558,712	8,760 Added 64.34%	22,376 $1.01 Million
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $360,814 - $480,050	7,965 Added 140.95%	13,616 $770,000
Q3 2020 Nov 16, 2020	BUY	$47.45 - $62.95 $268,139 - $355,730	5,651 New	5,651 $268,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.